KeyMed Biosciences Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - KeyMed Biosciences Inc

Watchlist Manager

Watchlist

Price: 59.45 HKD 0.68% Market Closed

Market Cap: HK$17.8B

K	KeyMed Biosciences Inc HKEX:2162	CN
	Ziprecruiter Inc NYSE:ZIP	US
	Iss A/S CSE:ISS	DK
A	Angel Oak Mortgage Inc NYSE:AOMR	US
K	Kaspi.kz AO NASDAQ:KSPI	KZ
	CrowdFundMe SpA MIL:CFM	IT
G	Gatos Silver Inc TSX:GATO	US
	Korn Ferry NYSE:KFY	US
	Tetra Technologies Inc NYSE:TTI	US

Profitability Summary

KeyMed Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

97% > 88%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-243%

Operating Margin is Increasing

-479% > -74%

Negative Net Margin

-73%

Negative 3Y Average Net Margin

-219%

Net Margin is Increasing

-308% > -73%

Negative Free Cash Flow Margin

-120%

Negative 3Y Average Free Cash Flow Margin

-322%

Free Cash Flow Margin is Increasing

-681% > -120%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-83% > -28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.